IMPACT THERAP-B_Providing professional financial news and data related to IMPACT THERAP-B, committed to creating a comprehensive and efficient information access channel for users | NewTimeSpace

IMPACT THERAP-B (07630.HK): Clinical Data of Senaparib, IMP1734 and IMP1707 Accepted for Poster Presentations at ESMO Congress 2026

Tags：

IMPACT THERAP-B 07630.HK poster presentation

2026-07-20

Finance
BILLION INDUSTRIAL HOLDINGS(02299.HK): Positive Profit Forecast, Interim Profit Attributable to Owners Expected to Surge by No Less Than 160%
Finance
Shenzhen Expressway Corporation Limited (00548.HK): Completes Issuance of Phase 2 Medium-Term Notes of 2026 in the Amount of RMB1 Billion
Finance
KINGDOM HOLDINGS (00528.HK): Expects to Swing to Profit in Interim Period with Net Profit of No Less Than RMB100 Million
Finance
GDS Global Secures New Contracts Worth Approximately S$6 Million in Singapore
Finance
FRASERS CENTREPOINT TRUST: Consortium Wins Tender for Mixed-Use Site at Bayshore Drive; Retail Mall Development Cost Estimated at S$613 Million
Finance
HS Optimus Holdings Completes Acquisition of 30% Stake in Medicorp Sdn Bhd
Research
HKIC-Backed Moonshot AI Releases Kimi K3, the World's Largest Open-Source Model by Parameter Scale, Claiming Top Spot on International Leaderboards
ETF
Samsung NYSE FANG+ ETF(02814.HK) Rises 0.96% Intraday with Average Trading Price of HK$48.336
ETF
CMS Hang Seng Tech Index ETF(03423.HK) Rises 1.35% Intraday, NAV Per Unit at HK$8.522
ETF
Chinaamc CSI 300 Index ETF(03188.HK) Rises 2.26% Intraday with AUM of HK$18.18 Billion

Scan QR Code

Download App